fig1
![B-cell receptor stereotyped subsets and outcome for patients with chronic lymphocytic leukemia in the HOVON 68 trial](https://image.oaes.cc/a14af8ee-2d28-47b1-aca3-b5e5814f03a8/4106.fig.1.jpg)
Figure 1. Outcome in the HOVON68 trial for patients belonging to subset #2 or utilizing IGHV3-21 by mutational status of IGHV. M-IGHV: Mutated immunoglobulin heavy chain genes; UM-IGHV: unmutated immunoglobulin heavy chain genes; #2: subset #2; 3-21: utilizing IGHV3-21; PFS: progression free survival; OS: overall survival.